According to TCGA data, higher expression of FGF9 was correlated with poorer overall survival in bladder carcinoma patients (Hazard ratio = 1.900 (95% CI = 1.079-3.345), logrank P = 0.0213, Figure 1B). This evidence concerns the gene FGF9 and urinary bladder carcinoma.